These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8486500)

  • 1. Magnetic resonance imaging contrast agents. Design and physicochemical properties of gadodiamide.
    Chang CA
    Invest Radiol; 1993 Mar; 28 Suppl 1():S21-7. PubMed ID: 8486500
    [No Abstract]   [Full Text] [Related]  

  • 2. The synthesis and screening of nonionic gadolinium (III) DTPA-bisamide complexes as magnetic resonance imaging contrast agents.
    Periasamy M; White D; deLearie L; Moore D; Wallace R; Lin W; Dunn J; Hirth W; Cacheris W; Pilcher G
    Invest Radiol; 1991 Nov; 26 Suppl 1():S217-20; discussion S232-5. PubMed ID: 1667003
    [No Abstract]   [Full Text] [Related]  

  • 3. Gadolinium-DTPA enhanced MRI in neonatal osteomyelitis of the cervical spine.
    Martijn A; van der Vliet AM; van Waarde WM; van Aalderen WM
    Br J Radiol; 1992 Aug; 65(776):720-2. PubMed ID: 1393402
    [No Abstract]   [Full Text] [Related]  

  • 4. Contrast-enhanced MR imaging of the female pelvis.
    Hricak H; Kim B
    J Magn Reson Imaging; 1993; 3(1):297-306. PubMed ID: 8428097
    [No Abstract]   [Full Text] [Related]  

  • 5. Contrast agents in magnetic resonance imaging.
    Roux E; De Broe L
    J Belge Radiol; 1988; 71(1):31-6. PubMed ID: 3372466
    [No Abstract]   [Full Text] [Related]  

  • 6. Magnetic resonance imaging with gadolinium-DTPA enhancement in the differentiation of benign from neoplastic cord cavitation.
    Clarke CE; Hawnaur J; Prvulovich E; Yuill GM; Bannister CM
    Clin Radiol; 1990 Mar; 41(3):214-6. PubMed ID: 2323169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical applications of gadolinium-DTPA in MRI.
    de Roos A; Doornbos J; Baleriaux D; Bloem HL; Falke TH
    Magn Reson Annu; 1988; ():113-45. PubMed ID: 3079294
    [No Abstract]   [Full Text] [Related]  

  • 8. [Artificial contrasting during magnetic resonance tomography].
    Sergeev PV; Panov OV; Egorova SV; Bolotova EN; Shimanovskii NL; Akhadov TA; Sviridov NK
    Vestn Rentgenol Radiol; 1997; (1):45-52. PubMed ID: 9133071
    [No Abstract]   [Full Text] [Related]  

  • 9. Dynamic imaging of contrast enhancement in brain tumors.
    Bullock PR; Mansfield P; Gowland P; Worthington BS; Firth JL
    Magn Reson Med; 1991 Jun; 19(2):293-8. PubMed ID: 1881318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Giant extra-adrenal pheochromocytoma: magnetic resonance imaging with gadolinium-DTPA enhancement.
    Terk MR; de Verdier H; Colletti PM
    Magn Reson Imaging; 1993; 11(1):47-50. PubMed ID: 8423721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-enhanced MRI of the central nervous system: comparison between gadodiamide injection and gadolinium-DTPA.
    Akeson P; Jonsson E; Haugen I; Holtås S
    Neuroradiology; 1995 Apr; 37(3):229-33. PubMed ID: 7603600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in macrocyclic gadolinium complexes as magnetic resonance imaging contrast agents.
    Meyer D; Schaefer M; Doucet D
    Invest Radiol; 1990 Sep; 25 Suppl 1():S53-5. PubMed ID: 2132570
    [No Abstract]   [Full Text] [Related]  

  • 13. [Value of contrast enhancement with Gd-DTPA in MRI of brain tumors. A comparison with X-ray CT].
    Tsuji T; Kishikawa T; Ikezaki K; Fujii K; Matsumoto S; Koga T
    Fukuoka Igaku Zasshi; 1987 Dec; 78(12):578-97. PubMed ID: 3447928
    [No Abstract]   [Full Text] [Related]  

  • 14. Subtracted synthetic images in Gd-DTPA enhanced MR.
    Suto Y; Caner BE; Tamagawa Y; Matsuda T; Kimura I; Kimura H; Toyama T; Ishii Y
    J Comput Assist Tomogr; 1989; 13(5):925-8. PubMed ID: 2778158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonionic magnetic resonance imaging contrast agents. Clinical trial experience of safety, tolerance, and efficacy of gadodiamide injection.
    Van Wagoner M; O'Toole M; Quay SC
    Invest Radiol; 1990 Sep; 25 Suppl 1():S39-41. PubMed ID: 2283251
    [No Abstract]   [Full Text] [Related]  

  • 16. Contrast-enhanced magnetic resonance imaging of the breast.
    Heywang-Köbrunner SH
    Invest Radiol; 1994 Jan; 29(1):94-104. PubMed ID: 8144345
    [No Abstract]   [Full Text] [Related]  

  • 17. Abdominal imaging.
    Stark DD; Fahlvik AK; Klaveness J
    J Magn Reson Imaging; 1993; 3(1):285-95. PubMed ID: 8428096
    [No Abstract]   [Full Text] [Related]  

  • 18. Gadolinium-DTPA enhanced MR imaging of intradural neurenteric cysts.
    Pierot L; Dormont D; Queslati S; Cornu P; Rivierez M; Bories J
    J Comput Assist Tomogr; 1988; 12(5):762-4. PubMed ID: 3170836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo quantification of the blood-brain barrier injury using magnetic resonance enhancement.
    Hayakawa K; Yamashita K; Mitsumori M; Nakano Y
    Invest Radiol; 1990 Sep; 25 Suppl 1():S80-1. PubMed ID: 2283266
    [No Abstract]   [Full Text] [Related]  

  • 20. Indications for gadolinium-DTPA in magnetic resonance evaluation of extracranial head and neck mass lesions: review of experience with 27 patients examined with a 2 tesla imager.
    Chisin R; Gomori JM; Elidan J
    Isr J Med Sci; 1992; 28(3-4):268-76. PubMed ID: 1592599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.